Stay updated on LN-144 Clinical Trial in Metastatic Melanoma
Sign up to get notified when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.

Latest updates to the LN-144 Clinical Trial in Metastatic Melanoma page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe NIH transition notice about using “Super Intelligence” alongside “Artificial Intelligence” is no longer displayed at the top of the page.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces NIH website transition updates and says agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden message.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study record page shows a 403 Forbidden message and a Home link in place of the study details.SummaryDifference0.5%

Stay in the know with updates to LN-144 Clinical Trial in Metastatic Melanoma
Enter your email address, and we'll notify you when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.